apo-go pen 10 mg/ml injektionsvæske, opløsning
stada arzneimittel ag - apomorphinhydrochlorid - injektionsvæske, opløsning - 10 mg/ml
apo-go pen 10 mg/ml injektionsvæske, opløsning
paranova danmark a/s - apomorphinhydrochlorid - injektionsvæske, opløsning - 10 mg/ml
levodopa/carbidopa/entacapone "rivopharm" 100+25+200 mg filmovertrukne tabletter
rivopharm limited - carbidopa, entacapon, levodopa - filmovertrukne tabletter - 100+25+200 mg
levodopa/carbidopa/entacapone "rivopharm" 125+31,25+200 mg filmovertrukne tabletter
rivopharm limited - carbidopa, entacapon, levodopa - filmovertrukne tabletter - 125+31,25+200 mg
levodopa/carbidopa/entacapone "rivopharm" 150+37,5+200 mg filmovertrukne tabletter
rivopharm limited - carbidopa, entacapon, levodopa - filmovertrukne tabletter - 150+37,5+200 mg
levodopa/carbidopa/entacapone "rivopharm" 200+50+200 mg filmovertrukne tabletter
rivopharm limited - carbidopa, entacapon, levodopa - filmovertrukne tabletter - 200+50+200 mg
levodopa/carbidopa/entacapone "rivopharm" 75+18,75+200 mg filmovertrukne tabletter
rivopharm limited - carbidopa, entacapon, levodopa - filmovertrukne tabletter - 75+18,75+200 mg
apo-go pumpfill 5 mg/ml infusionsvæske, opløsning
stada arzneimittel ag - apomorphinhydrochlorid - infusionsvæske, opløsning - 5 mg/ml
solymbic
amgen europe b.v. - adalimumab - arthritis, psoriatic; spondylitis, ankylosing; crohn disease; colitis, ulcerative; hidradenitis suppurativa; psoriasis; arthritis, rheumatoid - immunosuppressiva - se venligst afsnit 4. 1 i resuméet af produktegenskaber i produktinformationsdokumentet.
levodopa/carbidopa/entacapone "rivopharm" 175+43,75+200 mg filmovertrukne tabletter
rivopharm limited - carbidopa, entacapon, levodopa - filmovertrukne tabletter - 175+43,75+200 mg